PD-1 INHIBITORS
Clinical trials for PD-1 INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new PD-1 INHIBITORS trials appear
Sign up with your email to follow new studies for PD-1 INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can acupuncture boost lung cancer treatment? new trial aims to find out
Disease control Recruiting nowThis study tests whether adding electro-acupuncture to standard first-line treatment (PD-1 inhibitors plus chemotherapy) helps people with metastatic non-small cell lung cancer. About 424 participants will receive either real or sham acupuncture alongside their cancer therapy. Th…
Matched conditions: PD-1 INHIBITORS
Phase: NA • Sponsor: Guangzhou University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug shows promise in shrinking lung tumors before surgery
Disease control Recruiting nowThis study tests a new drug called Ivonescimab for people with non-small cell lung cancer who need surgery. The drug is given before surgery to shrink tumors and make them easier to remove. The study compares Ivonescimab to standard treatments and looks at how well it works and w…
Matched conditions: PD-1 INHIBITORS
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Acupuncture needles join fight against lung cancer
Disease control Recruiting nowThis study tests whether adding electroacupuncture (a type of acupuncture with mild electric current) to standard immunotherapy can help control advanced non-small cell lung cancer in patients who are too weak for aggressive treatment. 120 participants will receive either real or…
Matched conditions: PD-1 INHIBITORS
Phase: NA • Sponsor: Kong Fanming • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC